Azitra Faces NYSE American Non-Compliance Notice: Implications for Future Operations #USA #Azitra #ATR-12 #Branford #NYSE_American
Latest posts tagged with #Azitra on Bluesky
Azitra Faces NYSE American Non-Compliance Notice: Implications for Future Operations #USA #Azitra #ATR-12 #Branford #NYSE_American
Azitra, Inc. Announces Cancellation of 2026 Stockholders Meeting Due to Insufficient Quorum #United_States #Inc. #Azitra #ATR-12 #Branford #ATR-04
Azitra, Inc. Reveals 2025 Financial Results and Future Business Strategies #USA #dermatology #Azitra #Branford #ATR-04
Azitra Expands Clinical Trial for Skin Rash Treatment at MD Anderson Cancer Center #United_States #MD_Anderson #Azitra #ATR-04 #Conn
Azitra, Inc. Set to Showcase Innovations at BIO Investment & Growth Summit in 2026 #United_States #Miami_Beach #Azitra #ATR-12 #Precision_Dermatology
Azitra (AZTR) postponed its shareholder meeting after failing to reach quorum. The meeting resumes March 6, 2026.
aktiego.com/azitra-exten...
#Biotech #Healthcare #aktiego #azitra #Community #Innovation #Investing
Azitra (AZTR) postponed its shareholder meeting after failing to reach quorum. The meeting resumes March 6, 2026, with proposals on share issuance and financing.
aktiego.com/azitra-exten...
#Biotech #Healthcare #aktiego #azitra #Community #Innovation #Investing
Azitra, Inc. to Showcase at Biotech Event with J.P. Morgan Conference #United_States #San_Francisco #biotechnology #Azitra #ATR-12
Azitra, Inc. Takes Positive Steps Toward NYSE Compliance with New Listing Plan #USA #dermatology #Azitra #Branford #NYSE_American
Azitra, Inc. Secures $1.5 Million for Innovative Dermatology Therapies through Premium Private Placement #United_States #Azitra #ATR-12 #Branford #NYSE_American
Azitra, Inc. Reports Third Quarter 2025 Financial Results and Key Developments #United_States #Azitra #Branford #ATR-04 #ATR-01
Azitra, Inc. Reports Promising Preclinical Results for ATR-01 Solution Aiming to Address Ichthyosis Vulgaris #United_States #Azitra #Branford #ATR-01 #Ichthyosis
Azitra's Participation in Rare Disease Panel Highlights Innovative Dermatology Solutions at Maxim Growth Summit #USA #New_York_City #dermatology #Azitra #Netherton_syndrome
Azitra Inc. Faces NYSE American Compliance Challenge: A Path Ahead #United_States #Azitra #ATR-12 #Branford #NYSE_American
Azitra, Inc. Advances Clinical Trial for New Treatment of Dermatologic Toxicities Linked to Cancer Therapies #United_States #Azitra #Branford #ATR04-484 #EGFRi
We speak with Azitra’s COO Travis Whitfill about EGFRi associated rash and the rationale behind ATR-04.
$AZTR
#Azitra #NethertonSyndrome #RareDisease
Azitra, Inc. Reports Promising Q2 2025 Results and Future Directions in Dermatology #USA #Azitra #ATR-12 #Branford #Netherton_syndrome
Azitra Announces Key Safety Results from Phase 1b Trial Focused on Netherton Syndrome #USA #Azitra #Branford #Netherton_syndrome #ATR12-351
Azitra, Inc. Unveils Groundbreaking ATR-04 Clinical Trial Presentation at ASCO 2025 #United_States #Chicago #Azitra #Biomarker #EGFRi
Azitra, Inc. Unveils Key Findings at ASGCT on New Cancer Treatment Approach #United_States #New_Orleans #Azitra #ASGCT #ATR04-484
Azitra, Inc. Reports Progress on Clinical Trials and Financial Results for Q1 2025 #United_States #Azitra #ATR-12 #Branford #ATR-04
Azitra, Inc. to Provide Key Update on ATR-04 Program During ASCO 2025 Meeting #USA #Azitra #Branford #EGFR_inhibitors #ATR-04-484
Azitra Forms Partnership to Secure Up to $20 Million in Funding for Clinical Development #USA #Azitra #ATR-12 #Branford #Alumni_Capital
Azitra to Showcase Breakthrough Therapies at Microbiome Times Partnering Forum #United_States #Azitra #ATR-12 #Branford #Netherton_syndrome
Azitra, Inc. Reports 2024 Financials and Clinical Advancements in Dermatological Treatments #United_States #Azitra #ATR-12 #Branford #ATR-04
Azitra, Inc. to Showcase Innovations at BIO CEO Investor Conference in New York City #United_States #New_York_City #Azitra #ATR-12 #BIO_CEO
Azitra, Inc. Set to Showcase Innovative Dermatology Therapies at The Microcap Conference 2025 #United_States #Azitra #ATR-12 #Atlantic_City,_NJ #ATR-04
Azitra, Inc. Announces $1.5 Million Common Stock Public Offering Price #USA #Common_Stock #Azitra #ATR-12 #Branford,_Connecticut
Azitra, Inc. Plans New Public Stock Offering for Strategic Growth #United_States #Biopharmaceutical #Azitra #ATR-12 #Branford
Azitra, Inc. Prepares to Showcase Innovations at Biotech Showcase 2025 #USA #San_Francisco #Azitra #ATR-12 #Biotech_Showcase